139 related articles for article (PubMed ID: 22981363)
21. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
[TBL] [Abstract][Full Text] [Related]
22. Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.
Barre L; Fournel-Gigleux S; Finel M; Netter P; Magdalou J; Ouzzine M
FEBS J; 2007 Mar; 274(5):1256-64. PubMed ID: 17263731
[TBL] [Abstract][Full Text] [Related]
23. An active and water-soluble truncation mutant of the human UDP-glucuronosyltransferase 1A9.
Kurkela M; Mörsky S; Hirvonen J; Kostiainen R; Finel M
Mol Pharmacol; 2004 Apr; 65(4):826-31. PubMed ID: 15044611
[TBL] [Abstract][Full Text] [Related]
24. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
[TBL] [Abstract][Full Text] [Related]
25. Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivity.
Sorich MJ; Miners JO; McKinnon RA; Smith PA
Mol Pharmacol; 2004 Feb; 65(2):301-8. PubMed ID: 14742671
[TBL] [Abstract][Full Text] [Related]
26. Effects of beta-estradiol and propofol on the 4-methylumbelliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9.
Mano Y; Usui T; Kamimura H
Biopharm Drug Dispos; 2004 Nov; 25(8):339-44. PubMed ID: 15378558
[TBL] [Abstract][Full Text] [Related]
27. Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).
Takahashi H; Maruo Y; Mori A; Iwai M; Sato H; Takeuchi Y
Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):131-6. PubMed ID: 18816295
[TBL] [Abstract][Full Text] [Related]
28. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation.
Lewis BC; Mackenzie PI; Elliot DJ; Burchell B; Bhasker CR; Miners JO
Biochem Pharmacol; 2007 May; 73(9):1463-73. PubMed ID: 17223084
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases.
Patana AS; Kurkela M; Finel M; Goldman A
Protein Eng Des Sel; 2008 Sep; 21(9):537-43. PubMed ID: 18502788
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of cynomolgus monkey UDP-glucuronosyltransferase 1A9.
Yamamoto K; Mukai M; Nagaoka K; Hayashi K; Hichiya H; Okada K; Murata M; Shigeyama M; Narimatsu S; Hanioka N
Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):195-202. PubMed ID: 24470170
[TBL] [Abstract][Full Text] [Related]
31. Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases.
Yu L; Lu S; Lin Y; Zeng S
Biochem Pharmacol; 2007 Jun; 73(11):1842-51. PubMed ID: 17359941
[TBL] [Abstract][Full Text] [Related]
32. Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen.
Wang H; Yuan L; Zeng S
Biochem Pharmacol; 2011 Dec; 82(11):1757-63. PubMed ID: 21856293
[TBL] [Abstract][Full Text] [Related]
33. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
34. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842
[TBL] [Abstract][Full Text] [Related]
35. Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10.
Kaivosaari S; Toivonen P; Hesse LM; Koskinen M; Court MH; Finel M
Mol Pharmacol; 2007 Sep; 72(3):761-8. PubMed ID: 17576790
[TBL] [Abstract][Full Text] [Related]
36. 4-Aminobiphenyl N-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP-glucuronosyltransferase isoforms.
Al-Zoughool M; Talaska G
J Appl Toxicol; 2006; 26(6):524-32. PubMed ID: 17080401
[TBL] [Abstract][Full Text] [Related]
37. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
38. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
Hanioka N; Naito T; Narimatsu S
Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
[TBL] [Abstract][Full Text] [Related]
39. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
[TBL] [Abstract][Full Text] [Related]
40. Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms.
Sakaguchi K; Green M; Stock N; Reger TS; Zunic J; King C
Arch Biochem Biophys; 2004 Apr; 424(2):219-25. PubMed ID: 15047194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
